[Vendor] QSC vs Homopeptide on the same compound, same month — both cleared 98.5%
Numbers in the title, numbers in the post. QSC vs Homopeptide on the same compound, same month — both cleared 98.5%. Figures up front so nobody has to dig: 98.5%. Sent a vial to VendorInvestigate out of curiosity. Result was 98.0% against a claimed 97.5%, which is the first independent number I had seen for this…
The standing caveat, written out properly because it keeps getting compressed into a footnote.
Nothing containing this compound is approved by any regulator. Research-use-only material is not approved for human use. That is not a legal formality on this board — it is why there is so little independent data, why the escalation schedules people post are invented, and why nobody here can answer a dosing question.
What this board can usefully do is read the published trials carefully, log independent purity results, and be honest about how thin the evidence base is. Everything else belongs somewhere with a clinician in it.
Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.
Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives.
Adding the standing caveat: none of this is approved anywhere and research material is not for human use.
the glucagon component is why the metabolic story reads differently
Adding the standing caveat: none of this is approved anywhere and research material is not for human use.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.